AR and breast carcinoma: Using RNAseq and DNAseq analyses in a large breast cancer cohort, Ferguson et al. [76] reported the detection of ARV7 in primary, metastatic and recurrent breast cancer tissues and proposed testing for ARV7 as a predictive biomarker for AR antagonists.